Company Registration No. 13274564 (England and Wales)
City Group Medical Holdings Limited
Unaudited accounts
for the period from 17 March 2021 to 30 April 2022
City Group Medical Holdings Limited
Unaudited accounts
Contents
City Group Medical Holdings Limited
Company Information
for the period from 17 March 2021 to 30 April 2022
Directors
Douglas Ferguson
Jane Ferguson
Company Number
13274564 (England and Wales)
Registered Office
165 High Street
Honiton
Devon
EX14 1LQ
United Kingdom
Accountants
Griffin
165 High Street
Honiton
Devon
EX14 1LQ
City Group Medical Holdings Limited
Statement of financial position
as at 30 April 2022
Creditors: amounts falling due within one year
(780)
Called up share capital
10
For the period ending 30 April 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 21 August 2022 and were signed on its behalf by
Jane Ferguson
Director
Company Registration No. 13274564
City Group Medical Holdings Limited
Notes to the Accounts
for the period from 17 March 2021 to 30 April 2022
City Group Medical Holdings Limited is a private company, limited by shares, registered in England and Wales, registration number 13274564. The registered office is 165 High Street, Honiton, Devon, EX14 1LQ, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
These financial statements for the period from 17 March 2021 to 30 April 2022 are the first financial statements that comply with FRS 102 Section 1A Small Entities. The date of transition is 17 March 2021.
The transition to FRS 102 Section 1A Small Entities has resulted in a small number of changes in accounting policies to those used previously.
The nature of these changes and their impact on opening equity and profit for the comparative period are explained in the notes below.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
4
Investments
Subsidiary undertakings
Valuation at 17 March 2021
-
Valuation at 30 April 2022
10
5
Debtors: amounts falling due within one year
2022
Amounts due from group undertakings etc.
780
6
Creditors: amounts falling due within one year
2022
City Group Medical Holdings Limited
Notes to the Accounts
for the period from 17 March 2021 to 30 April 2022
Allotted, called up and fully paid:
10 Ordinary shares of £1 each
10
Shares issued during the period:
10 Ordinary shares of £1 each
10
8
Average number of employees
During the period the average number of employees was 0.